Showing results (2611-2620 of 13,857) with videos related to
Sort By:
Pageof 1,386
American Heart Journal|September 11, 2013
High-sensitive cardiac troponin T and its relations to cardiovascular risk factors, morbidity, and mortality in elderly menKai M Eggers, Jinan Al-Shakarchi, Lars Berglund, et al.American Heart Journal|September 11, 2013
Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trialDavid A Garcia, Lars Wallentin, Renato D Lopes, et al.American Heart Journal|November 2, 2013
Posttraumatic stress disorder and risk for coronary heart disease: a meta-analytic reviewDonald Edmondson, Ian M Kronish, Jonathan A Shaffer, et al.American Heart Journal|November 2, 2013
Gender-specific ambulance priority and delays to primary percutaneous coronary intervention: a consequence of the patients' presentation or the management at the emergency medical communications center?Tor Melberg, Bjørg Kindervaag, Jan RoslandAmerican Heart Journal|November 2, 2013
Cardiac biomarker measurement after elective percutaneous coronary interventions in older patients: insights from the National Cardiovascular Data RegistryTracy Y Wang, Lisa A McCoy, John C Messenger, et al.American Heart Journal|February 1, 1990
Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study GroupD W Muller, E J Topol, R M Califf, et al.American Heart Journal|February 1, 1990
Randomized double-blind comparison of side effects of nicardipine and nifedipine in angina pectoris. The Nicardipine Investigators GroupM A DeWood, R A WolbachAmerican Heart Journal|July 31, 2013
Methodology of a reevaluation of cardiovascular outcomes in the RECORD trial: study design and conductRenato D Lopes, Sheila Dickerson, Gail Hafley, et al.American Heart Journal|July 31, 2013
Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)--a randomized placebo-controlled trialBruce Neal, Vlado Perkovic, Dick de Zeeuw, et al.American Heart Journal|July 31, 2013
Impact of diabetes on 10-year outcomes of patients with multivessel coronary artery disease in the Medicine, Angioplasty, or Surgery Study II (MASS II) trialEduardo Gomes Lima, Whady Hueb, Rosa Maria Rahmi Garcia, et al.Pageof 1,386